New Delhi, Nov 13 (PTI) Drug maker Cipla on Wednesday said the US health regulator has issued eight observations after inspecting its Bengaluru-based plant.

The US Food and Drugs Administration (USFDA) conducted an inspection at the company's manufacturing facility in Virgonagar, Bengaluru from November 7- 13, the Mumbai-based based drug maker said in a filing to BSE.

Also Read | Who Is Aneesh Rajani? All You Need To Know About Husband of Om Birla’s Daughter Anjali Birla As Couple Ties Knot in Rajasthan’s Kota.

On conclusion of the inspection, the company received eight observations in Form 483, it added.

The company said it will work closely with the USFDA and remain committed to addressing these observations comprehensively within stipulated time.

Also Read | Shillong Teer Results Today, November 13 2024: Winning Numbers, Result Chart for Shillong Morning Teer, Shillong Night Teer, Khanapara Teer, Juwai Teer and Jowai Ladrymbai.

(This is an unedited and auto-generated story from Syndicated News feed, LatestLY Staff may not have modified or edited the content body)